A detailed history of Planning Directions Inc transactions in Cor Medix Inc. stock. As of the latest transaction made, Planning Directions Inc holds 50,000 shares of CRMD stock, worth $516,500. This represents 0.25% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$516,500
Previous $216,000 87.04%
% of portfolio
0.25%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 21, 2020

BUY
$3.08 - $6.56 $154,000 - $328,000
50,000 New
50,000 $315,000
Q1 2020

May 05, 2020

SELL
$2.35 - $7.08 $117,500 - $354,000
-50,000 Closed
0 $0
Q3 2019

Oct 25, 2019

BUY
$6.38 - $9.69 $319,000 - $484,500
50,000 New
50,000 $319,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $426M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Planning Directions Inc Portfolio

Follow Planning Directions Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Directions Inc, based on Form 13F filings with the SEC.

News

Stay updated on Planning Directions Inc with notifications on news.